Isovitexin Protects Mice from Methicillin- Resistant Staphylococcus aureus-Induced Pneumonia by Targeting Sortase A
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The rise of methicillin-resistant Staphylococcus aureus (MRSA) has resulted in significant morbidity and mortality, and clinical treatment of MRSA infections has become extremely difficult. Sortase A (SrtA), a virulence determinant that anchors numerous virulence-related proteins to the cell wall, is a prime druggable target against S. aureus infection due to its crucial role in the pathogenicity of S. aureus. Here, we demonstrate that isovitexin, an active ingredient derived from a variety of traditional Chinese medicines, can reversibly inhibit SrtA activity in vitro with a low dose (IC50=24.72 μg/ml). Fluorescence quenching and molecular simulations proved the interaction between isovitexin and SrtA. Subsequent point mutation experiments further confirmed that the critical amino acid positions for SrtA binding to isovitexin were Ala-92, Ile-182, and Trp-197. In addition, isovitexin treatment dramatically reduced S. aureus invasion of A549 cells. This study shows that treatment with isovitexin could alleviate pathological injury and prolong the life span of mice in an S. aureus pneumonia model. According to our research, isovitexin represents a promising lead molecule for the creation of anti-S. aureus medicines or adjuncts.
Abstract
The rise of methicillin-resistant Staphylococcus aureus (MRSA) has resulted in significant morbidity and mortality, and clinical treatment of MRSA infections has become extremely difficult. Sortase A (SrtA), a virulence determinant that anchors numerous virulence-related proteins to the cell wall, is a prime druggable target against S. aureus infection due to its crucial role in the pathogenicity of S. aureus. Here, we demonstrate that isovitexin, an active ingredient derived from a variety of traditional Chinese medicines, can reversibly inhibit SrtA activity in vitro with a low dose (IC50=24.72 μg/ml). Fluorescence quenching and molecular simulations proved the interaction between isovitexin and SrtA. Subsequent point mutation experiments further confirmed that the critical amino acid positions for SrtA binding to isovitexin were Ala-92, Ile-182, and Trp-197. In addition, isovitexin treatment dramatically reduced S. aureus invasion of A549 cells. This study shows that treatment with isovitexin could alleviate pathological injury and prolong the life span of mice in an S. aureus pneumonia model. According to our research, isovitexin represents a promising lead molecule for the creation of anti-S. aureus medicines or adjuncts.
참고문헌 (30)
- Diekema DJ, "Survey of infections due to Staphylococcus species:frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999", Clin. Infect. Dis, 32(2), pp.114~132 (2001)
- Turner NA, "Methicillin-resistant Staphylococcus aureus : an overview of basic and clinical research", Nat. Rev. Microbiol, 17, pp.203~218 (2019)
- Smeltzer MS, "Staphylococcus aureus pathogenesis : The importance of reduced cytotoxicity", Trends Microbiol, 24, pp.681~ (2016)
- Zuo QF, "Evaluation of the protective immunity of a novel subunit fusion vaccine in a murine model of systemic MRSA infection", PLoS One, 8, pp.e81212~ (2013)
- Geoghegan JA, "Cell wall-anchored surface proteins of Staphylococcus aureus : Many proteins, multiple functions", Curr. Topics Microbiol. Immunol, 409, pp.95~102 (2015)
- Foster TJ, "Surface protein adhesins of Staphylococcus aureus", Trends Microbiol, 6, pp.484~ (1998)
- Oliveira D, "Staphylococcus aureus toxins and their molecular activity in infectious diseases", Toxins(Basel), 10, pp.252~ (2018)
- AW M, "Sortase as a target of anti-infective therapy", Pharmacol. Rev, 60, pp.128~141 (2008)
- Mazmanian SK, "Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections", Proc. Natl. Acad. Sci. USA, 97, pp.5510~5515 (2000)
- Wang L, "The therapeutic effect of chlorogenic acid against Staphylococcus aureus infection through sortase A inhibition", Front. Microbiol, 6, pp.1031~ (2015)
- Jonsson IM, "The role of Staphylococcus aureus sortase A and sortase B in murine arthritis", Microbes Infect, 5, pp.775~780 (2003)
- Bubeck Wardenburg J, "Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia", Infect. Immun, 75, pp.1040~1044 (2007)
- Jonsson IM, "On the role of Staphylococcus aureus sortase and sortase-catalyzed surface protein anchoring in murine septic arthritis", J. Infect. Dis, 185, pp.1417~1424 (2002)
- Cascioferro S, "Sortase A : An ideal target for anti-virulence drug development", Microb. Pathog, 77, pp.105~112 (2014)
- Maresso AW, "Sortase as a target of anti-infective therapy", Pharmacol. Rev, 60, pp.128~141 (2008)
- He M, "A review on the pharmacological effects of vitexin and isovitexin", Fitoterapia, 115, pp.74~85 (2016)
- Ganesan K, "Molecular targets of vitexin and isovitexin in cancer therapy : a critical review", Ann. NY Acad. Sci, 1401, pp.102~113 (2017)
- Dan Mu, "Isovitexin, a Potential Candidate Inhibitor of Sortase A of Staphylococcus aureus USA300", Journal of Microbiology and Biotechnology, 28(9), pp.1426~1432 (2018), 한국미생물·생명공학회
- Lu C, "Staphylococcus aureus sortase A exists as a dimeric protein in vitro", Biochemistry, 46, pp.9346~9354 (2007)
- Mazmanian SK, "An iron-regulated sortase anchors A class of surface protein during Staphylococcus aureus pathogenesis", Proc. Natl. Acad. Sci. USA, 99, pp.2293~2298 (2002)
- Ton-That H, "Purification and characterization of sortase, the transpeptidase that cleaves surface proteins of Staphylococcus aureus at the LPXTG motif", Proc. Natl. Acad. Sci. USA, 96, pp.12424~12429 (1999)
- Kim D, "Flavonoids as mushroom tyrosinase inhibitors : a fluorescence quenching study", J. Agric. Food Chem, 54, pp.935~941 (2006)
- Trott O, "AutoDock Vina : improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading", J. Comput. Chem, 31, pp.455~461 (2010)
- Pierce LC, "Routine access to millisecond time scale events with accelerated molecular dynamics", J. Chem. Theory Comput, 8, pp.2997~3002 (2012)
- Romelia Salomon-Ferrer, "Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald", Journal of Chemical Theory and Computation, 9(9), pp.3878~3888 (2013), American Chemical Society (ACS)[DOI]
- Salomon-Ferrer R, "Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. explicit solvent particle mesh Ewald", J. Chem. Theory Comput, 9, pp.3878~3888 (2013)
- Niu X, "Molecular insight into the inhibition mechanism of cyrtominetin to α-hemolysin by molecular dynamics simulation", Eur. J. Med. Chem, 62, pp.320~328 (2013)
- Marraffini LA, "Sortases and the art of anchoring proteins to the envelopes of Gram-positive bacteria", Microbiol. Mol. Biol. Rev, 70, pp.192~221 (2006)
- Wang L, "Eriodictyol as a potential candidate inhibitor of sortase A protects mice from methicillin-resistant Staphylococcus aureus-induced pneumonia", Front. Microbiol, 12, pp.635710~ (2021)
- Chen S, "Sortase A contributes to pneumococcal nasopharyngeal colonization in the chinchilla model", FEMS Microbiol. Lett, 253, pp.151~154 (2005)